These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11526815)

  • 1. Bupropion and drug-induced parkinsonism.
    Jerome L
    Can J Psychiatry; 2001 Aug; 46(6):560-1. PubMed ID: 11526815
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 3. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 4. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
    Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
    Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonian syndrome induced by amlodipine: case report.
    Teive HA; Germiniani FM; Werneck LC
    Mov Disord; 2002 Jul; 17(4):833-5. PubMed ID: 12210888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual hallucinations from the addition of riluzole to memantine and bupropion.
    Pittenger C; Naungayan C; Kendell SF; Coric V; Malison R; Krystal JH; Sanacora GS
    J Clin Psychopharmacol; 2006 Apr; 26(2):218-20. PubMed ID: 16633160
    [No Abstract]   [Full Text] [Related]  

  • 7. The combination of buspirone and bupropion in the treatment of depression.
    Fava M
    Psychother Psychosom; 2007; 76(5):311-2. PubMed ID: 17700052
    [No Abstract]   [Full Text] [Related]  

  • 8. Gustatory and olfactory hallucinations under therapeutic dosing of bupropion.
    Kroemer S; Kawohl W
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E53. PubMed ID: 21677231
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of bupropion XR in treatment-resistant elderly patients: a case series study.
    Bergman J; Miodownik C; Palatnik A; Lerner V
    Clin Neuropharmacol; 2011; 34(1):17-20. PubMed ID: 21206361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination antidepressant therapy for major depressive disorder: speed and probability of remission.
    Stewart JW; McGrath PJ; Blondeau C; Deliyannides DA; Hellerstein D; Norris S; Amat J; Pilowsky DJ; Tessier P; Laberge L; O'Shea D; Chen Y; Withers A; Bergeron R; Blier P
    J Psychiatr Res; 2014 May; 52():7-14. PubMed ID: 24485847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of bupropion-induced stuttering.
    Fetterolf F; Marceau M
    Gen Hosp Psychiatry; 2013; 35(5):574.e7-8. PubMed ID: 22959418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion-induced hyponatremia.
    Kate N; Grover S; Kumar S; Modi M
    Gen Hosp Psychiatry; 2013; 35(6):681.e11-2. PubMed ID: 23764348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute dystonia resulting from abrupt bupropion discontinuation.
    Wang HY; Chou WJ; Huang TY; Hung CF
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):766-8. PubMed ID: 17218049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-type (limb-truncal and orofacial) bupropion-associated dyskinesia.
    Ferentinos P; Christodoulou C; Rizos E; Douzenis A; Lykouras L
    J Clin Psychopharmacol; 2010 Oct; 30(5):644-6. PubMed ID: 20841971
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute psychosis after administration of bupropion hydrochloride (Zyban)].
    Neumann M; Livak V; Paul HW
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S140-1. PubMed ID: 15570532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacology of smoking cessation in patients with mental illness.
    Selby P
    J Psychiatry Neurosci; 2006 Sep; 31(5):360. PubMed ID: 16951737
    [No Abstract]   [Full Text] [Related]  

  • 18. Transcranial magnetic stimulation as an antidepressant alternative in a patient with Brugada syndrome and recurrent syncope.
    Alampay MM; Haigney MC; Flanagan MC; Perito RM; Love KM; Grammer GG
    Mayo Clin Proc; 2014 Nov; 89(11):1584-7. PubMed ID: 25444490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features.
    Seo HJ; Lee BC; Seok JH; Jeon HJ; Paik JW; Kim W; Kwak KP; Han C; Lee KU; Pae CU
    Pharmacopsychiatry; 2013 Sep; 46(6):221-6. PubMed ID: 23963965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.